Group A streptococcal vaccines: Paving a path for accelerated development
- 1 April 2013
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 31, B216-B222
- https://doi.org/10.1016/j.vaccine.2012.09.045
Abstract
No abstract availableFunding Information
- Decade of Vaccines Consultancy
- World Health Organization's Initiative for Vaccine Research
This publication has 53 references indexed in Scilit:
- New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciVaccine, 2011
- Global research priorities in rheumatic fever and rheumatic heart diseaseAnnals of Pediatric Cardiology, 2011
- Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based VaccineInfection and Immunity, 2010
- Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopesVaccine, 2010
- Prevalence of Rheumatic Heart Disease in Children and Young Adults in NicaraguaThe American Journal of Cardiology, 2010
- emmand C-Repeat Region Molecular Typing of Beta-Hemolytic Streptococci in a Tropical Country: Implications for Vaccine DevelopmentJournal of Clinical Microbiology, 2009
- Clinical and Microbiological Characteristics of SevereStreptococcus pyogenesDisease in EuropeJournal of Clinical Microbiology, 2009
- Epidemiology of Severe Streptococcus pyogenes Disease in EuropeJournal of Clinical Microbiology, 2008
- Active and Passive Immunizations with the Streptococcal Esterase Sse Protect Mice against Subcutaneous Infection with Group A StreptococciInfection and Immunity, 2007
- Proteomic Analysis and Identification of Streptococcus pyogenes Surface-Associated ProteinsJournal of Bacteriology, 2007